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The need for reliable information regarding the
incidence and prevalence of occupational diseases is
obvious to public health oflBcials who have to allocate
scarce resources to the investigation and prevention of
such diseases. Many data sources on occupational
diseases are available. They include workers' compen-
sation systems, hospital discharge records, cancer and
death registries, etc. Unfortunately, all these sources
have their own limits and consequently reliable data are
often unavailable1. Even diseases with a well-known
association with work, such as pleural mesothelioma or
sinonasal adenocarcinoma, are often not reported. Skov
et al.2 estimate that under-reporting of these two
occupational cancers is close to 50%. Considerable
under-reporting has also been noticed in Switzerland
for carpal tunnel syndrome3. Late recognition of
occupational diseases may have medical as well as
economic consequences. For instance, early diagnosis
of an isocyanate asthma case might cost the Swiss
National Insurance Company approximately 19000
Swiss francs, while late diagnosis costs about 211 000
Swiss francs4.
In Switzerland, about 5400 occupational disease cases
are compensated each year3. There were only 58
certified occupational physicians in the country in 1992,
which means that most cases are diagnosed in a regular
medical practice. Nevertheless, many physicians are
probably not adequately trained to recognize work as
a cause of illness1.
Both clinical and workplace information with reliable
exposure evaluation are critical in the recognition and
management of occupational disease. Occupational
health centres with their clinical and industrial hygiene
services are a unique resource for detecting adverse
health effects secondary to occupational exposures6. For
instance, in a retrospective study among 298 patients
examined at the outpatient clinic of the Institute
of Occupational Health Sciences of the University
of Lausanne, it was interesting to observe that
the spectrum of disease is quite different to that
usually observed for workers' compensation systems.
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Approximately half of these patients have health
problems directly due to their occupation. However,
instead of the usual general prevalence of musculoskeletal
or stress-related disorders, the cases were mainly
represented by respiratory diseases (41 %) and intoxica-
tions (31%), in which solvents are often involved.
This discrepancy can be explained by the fact that
simple conditions such as contact dermatitis or tendonitis
are more easily recognized by insurance companies as
work-related. Conditions such as occupational asthma
or chronic solvent intoxication may go unrecognized.
In contrast, complex conditions are more often seen in
occupational health clinics and may be over-represented.
Despite these referral biases, and with the exception of
asbestos-related problems which are not very frequent
in Switzerland, the results previously mentioned are
similar to those of Cullen and Cherniack in Connecticut7.
In some European countries, an increasing number
of workers are currently receiving compensation benefits
for chronic solvent neurotoxicity, although specific and
objective clinical data are often not available. In
Switzerland, only 65 cases of acute and chronic solvent
intoxication were recognized in 1989 by the Swiss
National Insurance Company (about 1 % of all compen-
sated occupational diseases)5. In our retrospective
study, most cases of suspected chronic solvent intoxication
remained unresolved due to insufficient objective and
specific clinical data. Only six cases were recognized as
solvent-related with a sufficient probability. One
example of insufficient objective data is the lack of
determination of urinary dimethylbenzoic acid in
workers exposed to white spirit8, despite the wide use
of this solvent by painters and related workers. These
results confirm that chronic solvent neurotoxicity is
particularly difficult to demonstrate on an individual
basis and that it remains one of the most difficult
diagnoses for occupational physicians.
If preventive measures are only based on data
obtained from compensated occupational disease, this
does not take into account the numerous situations
where the ailment is only partially related to work9.
This is particularly true for diseases such as depressive
states and back problems. For instance, in 1989, only
five cases of back problems were compensated as
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occupational disease in Switzerland out of a workforce
of approximately two million. Compared to the prevalence
of these problems in daily life, we do not need much
statistical analysis to conclude that they are under-
reported.
The main objective of occupational medicine is the
prevention of work-related problems, which cannot be
achieved by simple analysis of compensated diseases.
A better estimation of the reality needs a prospective
approach, particularly.
• promotion of risk analysis and management, in
cooperation with industrial hygienists
• an increase in the training of physicians in the
recognition of work as a cause of illness or ailment
• establishment of epidemiological surveillance and
clinical studies to provide detailed exposure data,
particularly in the recognition of new environmental
hazards
• assessment of occupational risk on an individual
basis, in order to consider inter-individual variation.
The difficulties encountered in the recognition of
many occupational diseases (particularly due to long
latency and the lack of objective diagnostic criteria)
imply a need for multiple data sources.
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